BUCCASTEM M Buccal tablet Ref.[50140] Active ingredients: Prochlorperazine

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB

Product name and form

Buccastem M Buccal Tablets.

Pharmaceutical Form
Buccal tablet.

Qualitative and quantitative composition

Each buccal tablet contains 3.0 mg prochlorperazine maleate.

Excipients with known effect: Compressible sugar (contains sucrose) 49.493 mg.

Active Ingredient	Description
Prochlorperazine	Prochlorperazine belongs to the phenothiazine group. Prochlorperazine has a wide range of activity arising from its depressant actions on the CNS and its alpha-adrenergic blocking and weaker anti-muscarinic properties. It inhibits dopamine and prolactin-release-inhibitory factor, thus stimulating the release of prolactin.

List of Excipients
Compressible sugar Povidone K30 Xanthan gum Locust bean gum Talc Magnesium stearate Riboflavin sodium phosphate

Pack sizes and marketing

250 micron PVC/PVdC aluminium foil blister packs.

Pack size: Blister packs of eight tablets.

Marketing authorization holder

Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB

Marketing authorization dates and numbers

PL 16853/0102

16^th February 2010

Drugs

Drug	Countries
BUCCASTEM	New Zealand, United Kingdom

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.